**Specifications Table**TableSubject areaDevelopmental BiologyMore specific subject areaLung DevelopmentType of dataTable, image, text file, graph, figureHow data was acquired3D Confocal Microscope inverted A1Rsi (Nikon Instruments, Melville, NY), fluorescent activated sorting flow cytometry (LSR II, BD Bioscience), MACS microbeads (Miltenyi Biotec technology, Gladbach, Germany), RNA-Seq (Illumina Inc. San Diego, CA, USA).Data formatFiltered, analyzedExperimental factorsSamples were not pretreatedExperimental featuresThe transcriptional profile, temporal, spatial and functional roles of PDGFα^GFP^ expressing fibroblasts were examined at different stages of acinar lung development using RNA-Seq, confocal microscopy and flow cytometry, respectively.Data source locationCincinnati, OH 45229, USAData accessibilityData is incorporated with this articleData is accessible at: <https://research.cchmc.org/pbge/lunggens/mainportal.html>

1. Data {#s0005}
=======

The data presented herein are representative of the key stages of acinar lung development and define the developmental role of lung interstitial fibroblasts expressing platelet-derived growth factor alpha (PDGFRα). Cells expressing PDGFRα were analyzed at E16.5, E18.5, P7 and P28. The spatiotemporal localization of PDGFRα^GFP^ E18.5 at ([Fig. 1](#f0005){ref-type="fig"}) demonstrates the relationship of PDGFRα^+^ fibroblasts to proximal and distal saccular lung structures. Flow cytometry using direct flow cytometry of whole-lung single cell suspension preparation and selection by differential adherence in tissue culture to enrich and analyze PDGFRα^+^ fibroblast populations is presented in [Fig. 2](#f0010){ref-type="fig"}. PDGFRα^GFP^ expression was assessed at E16.5, P7, and P28 for GFP^dim^ and GFP^bright^ sub-populations. For the two distinct sub-populations present at P7, the relative abundance of myofibroblasts (αSMA^+^) and lipofibroblasts (LipidTOX^+^) within each population is presented ([Fig. 3](#f0015){ref-type="fig"}). [Fig. 4](#f0020){ref-type="fig"} shows data on temporal changes in neutral lipid, αSMA, proliferation, and cell surface expression of CD34, CD29, and Sca-1 in CD326^+^, CD31^+^, CD140^+^ and CD140a^neg^ stromal cells. The gene expression profile from RNA-Seq data provides information in cell-cycle gene changes of isolated PDGFRα^+^ fibroblasts throughout acinar lung development ([Fig. 5](#f0025){ref-type="fig"} and [Table 1](#t0005){ref-type="table"}), individual genes upregulated at E18.5 in PDGFRα^+^ fibroblasts ([Table 2](#t0010){ref-type="table"}), and changes in contractile gene expression in PDGFRα^+^ fibroblasts ([Table 3](#t0015){ref-type="table"}). Additionally, data from computational transcription factor binding site analyses ([Table 4](#t0020){ref-type="table"}), ChIP-Seq enrichment profiles ([Table 5](#t0025){ref-type="table"}), and promoter sequences of individual genes dynamically expressed by PDGFRα^+^ fibroblasts during acinar lung development. The three transcription factors identified by ChIP-Seq analysis are presented in [Table 6](#t0030){ref-type="table"}.Fig. 1Spatial distribution of PDGFRα^GFP^ cells during the saccular stage of development. Confocal microscopy of lung sections from E18.5 PDGFRα^GFP^ mouse lungs co-stained with αSMA and pro-SPC to demonstrate the relationship of PDGFRα^GFP^ cells to saccular epithelial cells and contribution to αSMA-containing developing conducting airways (A) and blood vessels (B). Images obtained with 40X objective.Fig. 1Fig. 2Proportions and characteristics of PDGFRα^GFP^ cells obtained by direct FACS compared to isolation by differential adherence. Flow cytometry profile of lung cell lineage proportions and PDGFRα^GFP^ proportions of fresh whole cell suspension or after selection by differential adherence. Single cell suspensions were stained and subjected to FACS directly after isolation (whole prep) or following incubation for 2 h to obtain non-adherent cells (supernatant) and adherent stromal cells (adherent). (A) Relative proportion of hematopoietic (CD45^+^), epithelial (CD326^+^), endothelial (CD31^+^), CD140a^+^ (PDGFRα^+^) stromal, and CD140a^neg^ stromal cell populations analyzed by FACS in samples obtained from whole-lung suspension vs. non-adherent and adherent cells following differential adherence. (B) Distribution of PDGFRα-GFP^bright^ and PDGFRα-GFP^dim^ stromal cells contained in non-adherent and adherent cell fractions following differential adherence. (C) Proportion of PDGFRα-GFP^bright^ (dark green) and PDGFRα-GFP^dim^ (light green) fibroblasts contained in single cell suspensions by direct FACS or FACS following differential adherence. (D) The relative proportion CD29^+^, CD34^+^CD29^+^, CD34^+^ or CD29^-^CD34^-^ subpopulations in CD140a^+^ cells analyzed by direct FACS or FACS following differential adherence.Fig. 2Fig. 3Assessment of PDGFRα-GFP interstitial fibroblasts for PDGFRα-GFP^dim^ and PDGFRα-GFP^bright^ subpopulations. Flow cytometry profiles of PDGFRα^GFP^ dim and bright sub-populations throughout acinar lung development. (A) Relative proportions at E16.5, P7, and P28 of PDGFRα-GFP^dim^ and PDGFRα-GFP^bright^ subpopulations. (B-C) Contribution of αSMA^+^ myofibroblasts (B) and LipidTOX^+^ lipofibroblasts (C) to the discernible PDGFRα-GFP^dim^ and PDGFRα-GFP^bright^ subpopulations that comprise the pool of P7 PDGFRα-GFP interstitial fibroblasts. (E) Quantification of GFP^dim^ and GFP^bright^ in CD140 positive cells. (F) Quantification of GFP^dim^ and GFP^bright^ in all GFP positive cells. (F) Histogram overlay of GFP intensity in E16.5, PN7 and PN28 GFP cells.Fig. 3Fig. 4Temporal profiles of proliferation, neutral lipid, αSMA and surface marker expressions of CD45^+^, CD326^+^, CD31^+^, CD140a^+^ stromal and CD140a^neg^ stromal cell lineages. Proliferation, αSMA, lipid, CD29, CD34 and Sca-1 expressions of CD45^+^ hematopoietic (A), CD31^+^ endothelial (B), CD326^+^ epithelial (C), CD140a^+^ stromal (D) or CD140a^-^ stromal (E) cells at E16.5 (canalicular), E18.5 (saccular), P7 (early alveolar), P21 (mid alveolar), and P28 (late alveolar) stages of acinar lung development. Data is presented as the relative percentage of cells within each individual cell lineage.Fig. 4Fig. 5Transcriptional profile of cell cycle genes expressed in PDGFRα^+^ fibroblasts throughout critical stages of acinar lung development. Expression profile obtained by Bayesian and STEM analysis of RNA-Seq data to identify cell cycle genes that are differentially expressed in PDGFRα^+^ fibroblasts between E16.5, E18.5, P7, and P28 during acinar lung development.Fig. 5Table 1Cell cycle genes that are differentially expressed in PDGFRα^+^ fibroblasts during distinct stages of acinar lung development.Table 2GeneE16E18PN7PN28Calm2−0.00571762−0.8708331.40198−0.525428Dusp1−0.621371−0.627324−0.22441.47309Pmp22−0.742166−0.9794940.7986820.922978Sptbn1−0.789379−0.9360420.9407080.784713Srsf50.236167−1.084521.26328−0.414932Hsp90aa11.41313−0.874767−0.484744−0.0536168Rhoa−0.135108−1.067331.34942−0.146979Tubb50.832279−0.9580580.894011−0.768232Thbs10.8724030.828917−0.622006−1.07931Gnai2−0.147148−1.032871.36953−0.18952Jun−0.851524−0.510853−0.0556641.41804Anapc131.1925−0.897243−0.7514970.456244Gnb2l11.40582−0.040552−0.47046−0.89481Stmn10.934956−1.092280.757047−0.599728Smc1a0.883569−1.007340.835485−0.711719Tuba1a−0.354266−0.8397461.45038−0.256367Pcna1.26778−0.6424120.313621−0.938985Rhob−0.535957−1.110430.5737821.0726Ywhah0.729312−1.249870.880943−0.360389Calm10.056566−1.429030.7664160.606044Mapre2−0.362037−0.8617111.44181−0.218067Sept2−0.191729−0.8693141.43734−0.376292Plk2−0.294531−0.4635031.47699−0.718961Rad210.830549−1.057830.876974−0.649691Txnip−1.04578−0.3218950.02524661.34242Cdk41.21118−0.8895790.426562−0.74816Trp530.304485−1.029121.25272−0.528087Ube2c1.31111−0.7502890.249112−0.809935Sept4−0.884936−0.734290.3813851.23784Mapk3−0.467964−1.059531.259620.267868Chd40.965382−1.066580.73079−0.629589Csnk1a10.145345−0.4585971.32271−1.00946Sept110.38547−0.8347811.23797−0.788659Cetn30.920627−1.398940.4404210.0378935Nsmce20.927752−1.126490.751502−0.552767Ppp1cc0.757517−0.9619190.962431−0.758029Ppp1ca0.769955−1.199870.876423−0.446511Smc41.16898−0.7984640.49566−0.866176Ppp1cb−0.197787−1.113431.31193−0.0007138Smc31.1891−1.039880.422153−0.571375Cks1b1.34665−0.6296370.15774−0.874757Sept7−0.183509−0.8786181.43392−0.371793Mki671.18879−0.7287540.459143−0.919178Spin10.10549−0.9433861.35379−0.515895Top2a1.20696−0.8060170.43718−0.838125Tubb4b0.286298−1.448050.3103880.851369Kmt2e0.0343548−1.372760.9998740.33853Rgs2−0.02960691.39706−0.446672−0.920779Son0.19415−1.316861.108140.0145653Gnai30.490256−1.249351.05433−0.295233Cdkn1c1.41418−0.105178−0.397307−0.911693Usp9x0.0760878−1.43670.727690.632917Zak−0.700217−1.015320.9181070.797432Ier30.9804320.73242−0.723419−0.989433Wapal0.632021−1.233070.971144−0.370096Anapc50.682133−1.373080.798597−0.10765Ppm1g0.965661−1.349650.485437−0.101447Specc1l−0.56199−0.715791−0.1843491.46213Nedd9−0.579639−1.042441.172820.449265Ube2i0.696443−1.441550.6547930.0903107Sirt2−0.128286−1.198341.241050.0855696Usp470.972221−1.255560.60976−0.326424Nasp1.35164−0.6506950.151524−0.85247Ccar11.19936−0.858780.448599−0.789176Lats2−0.50131−1.121811.105640.517486Ccny0.0769666−1.097661.30669−0.285998Calm30.207701−1.121161.25756−0.344101Eid1−0.207967−0.9324921.41784−0.277379Foxn3−0.353993−1.185681.146370.393299Mtus1−0.231669−1.049711.35605−0.0746687Usp80.0653615−1.321360.1479071.10809Ran1.27067−0.9822250.291102−0.579552Cdc1230.684283−1.307010.872431−0.249708Ccnt10.350793−1.486930.6695010.466636Ppp6c−0.0845592−1.251981.184140.152397Dynlt3−0.662532−1.025281.050670.637141Smarca40.897716−0.9661860.827408−0.758938Pafah1b1−0.0028538−1.058041.34217−0.281278Trp53bp20.0115787−1.341681.062030.268075Marveld1−0.809342−0.8486671.182720.475286Ccndbp1−0.23958−1.271971.05770.453849Ccpg1−0.647646−0.9297980.3029941.27445Cdk60.385309−0.9581411.22701−0.654178Ctgf−0.476914−1.056910.2774271.2564Khdrbs10.834267−0.8191320.89601−0.911146Arl8b0.352736−1.470680.349490.768457Nudc1.41244−0.834935−0.023113−0.554394Anxa1−0.049034−0.778171−0.5987991.426Nipbl0.583539−1.212211.01876−0.390092Stag10.412112−1.084821.18106−0.508359Junb0.4109531.17702−1.09807−0.489902Cdk11b0.0832837−1.205261.2359−0.113924Cast−0.2003−1.330320.6685220.862097Klhl90.406837−1.354940.998055−0.0499484Ctcf0.823152−1.163130.845177−0.505199Usp160.280098−1.434470.8914830.262886Pcnp0.473111−1.325070.999318−0.147358Brd70.444032−1.497620.477130.576461Cdkn1a0.09162680.462374−1.42250.868503Cdc5l1.11105−1.15790.483718−0.436864Psme31.21813−1.164590.254701−0.30825Ckap50.976807−0.9641730.740723−0.753357Setd80.947553−1.263960.634908−0.318502Erh1.03215−1.00910.665275−0.688322Sept90.555875−0.6844081.11649−0.987952Gas6−0.610436−0.642252−0.2193121.472Yeats41.06306−1.193860.532339−0.401537Ralb0.445575−0.9096591.19804−0.733953Hcfc11.0087−1.156470.636994−0.489225H2afx1.36257−0.7603650.137039−0.73924Ccnd2−0.26808−0.7274081.47332−0.477836Mapre10.403968−0.8455791.22686−0.78525Ep3000.310167−1.460510.3416530.80869Tacc1−0.582128−0.8593330.05598691.38547Table 2Genes upregulated in PDGFRα^+^ fibroblasts at E18.5 relative to other stages of acinar lung development.Table 3GeneE16E18PN7PN28ADAMTS1−1.09961.89932−0.7786150.109199HBA-A1−0.721841.89803−0.602954−0.736058HBB-BT−0.6982841.89715−0.648254−0.725893OLFR62−0.6584341.89326−0.719626−0.719626HBB-B1−0.7010921.8915−0.598885−0.7459ENPP2−0.6967221.89078−0.611701−0.668638GM17644−0.7437821.88918−0.860528−0.1969814930470H14RIK−1.126711.88433−0.7944990.185705LARS2−0.7120291.88186−0.874364−0.206367PENK−0.6977631.8681−0.466888−0.81606PROS1−1.429721.85969−0.092791−0.456466MT1−0.5474241.82338−0.993104−0.15854GM10052−0.1668821.70856−0.893127−0.893127TGFBR3−1.644781.69903−0.3538730.405727HBB-Y−0.1271851.68753−0.892553−0.910755TRIB1−0.1151121.65209−1.06878−0.363624RGS2−0.0705951.59547−0.557646−1.11131ALDH2−0.9166571.55663−1.196670.944171NDRG2−0.780571.55655−1.268410.882676ODC1−0.0385731.55499−0.483119−1.21095HHIP0.1886241.48161−0.840506−0.864842SPRED1−0.1490311.45532−0.070748−1.56369ZFP360.2266831.45129−1.11433−0.463834BC1170900.3038441.42934−1.00008−1.00008HBA-X0.3738351.37937−1.01109−1.01109MYC0.1497691.35186−0.277893−1.49285SNORA520.4151081.34884−1.01697−1.01697RMRP0.3517731.29452−1.3491−0.068137MAFF0.4378031.28682−0.755838−1.05255JUNB0.4634681.27891−1.14282−0.495453IIGP10.2462621.27624−0.268592−1.53017CCDC3−1.243721.256110.861579−1.345771500012F01RIK0.455291.25174−0.659759−1.17327BHLHE400.5445171.19043−1.25119−0.321188FAU0.6229481.15584−0.922513−0.866115BTG20.6329111.11406−1.25966−0.320921HSPB1−0.8668611.1016−1.242011.53001RPPH1−0.0460671.05871−1.605451.10958KLF9−1.240711.04622−0.9062751.56238ATF30.8110230.98054−1.12267−0.576751SOCS30.8708320.928448−1.02609−0.729075ITGAV−0.7126330.9167351.02392−1.81532SLC2A10.8911610.905855−1.0727−0.655793THBS10.9006030.854342−0.689139−1.17562IFRD10.2179540.829998−1.657681.15147SKIL0.1572350.7771330.584415−2.05964EIF3E0.938360.777077−0.563455−1.31203H191.032270.774112−0.959012−1.08616CCNL11.026740.764284−0.973248−0.792439IER31.015160.75419−0.777739−1.05766EEF1A10.8939560.731323−0.340296−1.53243CDKN1A0.2569190.726925−1.662591.24179IGF21.054410.725075−0.829588−1.09723ELN−1.818890.7056910.8912420.0251241LOX1.108470.663704−1.10496−0.568685SNORA151.174830.621342−1.02944−1.02944MMP2−0.115030.562767−1.528051.71138FMO2−1.017890.561459−0.9006951.89521PTN1.192770.559803−0.808516−1.06382HES11.134260.553428−0.544956−1.29785TREM31.237460.5435−1.02013−1.02013PLAGL11.115390.540813−0.457605−1.38903SNORA751.246160.532386−1.01866−1.01866GLUL−1.679740.528690.07901041.29294EDNRB1.225490.501732−0.735441−1.08308Table 3Transcriptional profile of contractile genes differentially expressed in PDGFRα^+^ fibroblasts over the course of acinar lung development.Table 4GeneE16E18PN7PN28Sparc−0.782064−0.8840340.5022011.1639Npm11.3844−0.154564−0.225484−1.00435Sod1−0.106237−1.298610.3052181.09963Vim−0.32131−0.8673331.44228−0.253635Eln−1.430450.6101920.7601750.0600839Tpm1−0.297888−0.09210751.38385−0.993852Pfn11.07808−1.017290.602467−0.663255Tmsb4x0.783135−1.23122−0.3966060.844691Tgfbi−0.2013840.3218781.13319−1.25368Fhl1−0.834609−0.8258040.4816461.17877Myadm−0.950365−0.747321.069360.628329Gng50.799333−1.396430.63971−0.0426118Tmsb100.134493−0.8687771.35647−0.622189Fn1−0.568048−0.828443−0.0144631.41095Rac1−0.170999−0.9672671.402−0.263733Cfl10.952984−0.7980670.771927−0.926844Msn−0.353353−1.042341.336080.0596072Arpc20.673331−1.256460.923198−0.340072Fbn1−0.745338−0.9717350.744450.972623Itgb1−0.573494−0.6061451.48646−0.306817Arf10.0803654−1.297981.141490.0761276Cdh110.801392−1.3670.68846−0.122848Rhoa−0.135108−1.067331.34942−0.146979Cald1−0.306922−0.7237121.47733−0.446696Mmp2−0.201580.299274−1.245721.14803Myl60.415826−1.297621.0551−0.173303App−0.830414−0.8776261.055870.652173Ctnnb1−0.136582−1.314221.043030.40777Gnai2−0.147148−1.032871.36953−0.18952Cdc420.368935−1.111461.19372−0.451196Igf11.346530.102391−0.472771−0.976149Mylk0.0820497−0.8924431.37175−0.561356Cav1−0.71922−0.7445831.386480.0773188Flna0.713322−1.179970.936876−0.470232Gnb2l11.40582−0.0405521−0.47046−0.89481Tnc−0.424942−0.2950521.47202−0.752022Tpm30.592418−0.6965411.09092−0.986797Capzb0.642076−1.232330.964042−0.373784Ctnnd1−0.483005−0.8860221.4072−0.0381741Akap2−0.574534−0.490271.49745−0.432647Myh100.222398−1.366761.034630.109729Gnb10.0972075−1.157171.26814−0.208171Hspb1−0.7186610.699476−0.9889261.00811F2r−0.749158−0.9121920.4940551.1673Ednra1.13125−1.15915−0.4197920.447694Rhob−0.535957−1.110430.5737821.0726Sptan1−0.603347−0.9034811.338410.168423Cul30.560345−1.286610.982377−0.256117Myh110.459331−0.1023650.986597−1.34356Pdlim3−0.5710510.02860091.39505−0.852598Rdx−0.197531−1.103171.32045−0.0197473Myh9−0.079762−0.6357711.43791−0.722382Zyx−0.379613−1.088240.1887981.27906Dstn−0.768233−0.7330850.1401561.36116Actr31.3969−0.260784−0.977504−0.158609Bmp4−0.288633−1.283640.9144520.657823Cyb5r3−0.745596−0.9072061.18360.4692Cdk41.21118−0.8895790.426562−0.74816Aldoa0.826149−1.14381−0.5335230.851188Cdh5−0.650899−0.6447391.46062−0.164986Ghr0.275738−0.762861.29793−0.810804Atp2a2−0.51177−1.147860.9770060.682622Ltbp2−0.596826−0.08239891.4365−0.757278Pls30.23697−1.203581.20027−0.233664Cap10.554204−1.360450.911563−0.105319Lima1−0.323465−1.154671.223660.254468Dpysl2−0.696809−1.018720.8071330.908401Ppp1ca0.769955−1.199870.876423−0.446511S100a100.0334959−1.01683−0.3689881.35232Slc9a3r2−0.786913−0.8332941.242450.377755Marcks−0.095569−0.2866771.38184−0.999596Sorbs3−0.673773−0.9149121.26710.32158Fus0.644405−0.7555231.0575−0.946377Gsn−0.512083−0.503138−0.4846821.4999Nckap1−0.301663−1.201171.161870.340968Add1−0.311211−1.2181.118430.410786Tgfbr2−0.717995−0.9127990.4144361.21636Cd440.0409719−0.8053951.39648−0.632058Tns3−0.464562−1.035930.2092861.29121Actn10.458479−1.07621.15762−0.539902Wasf2−0.352504−1.079251.301540.130213Dlc1−0.741294−0.8792961.237010.383584Rap1gap−0.481962−0.533931−0.4836721.49956Dnajb61.06517−1.349270.1895530.0945508Lcp11.41617−0.90207−0.101197−0.412904Cdkn1c1.41418−0.105178−0.397307−0.911693Sdc4−0.63846−0.381346−0.4716631.49147Tmod3−0.388687−1.175161.132010.431829Net1−0.145783−0.078991.32632−1.10154Iqgap1−0.257395−1.235110.3625581.12995Kank2−0.552174−1.127440.9217460.757869Pecam1−0.675754−0.6208071.45989−0.163329Slk−0.082074−0.9477221.39944−0.369648Specc1l−0.56199−0.715791−0.1843491.46213Rock2−0.752439−0.8939990.4495751.19686Atf30.7617610.925637−1.10758−0.579823Actn4−0.441928−1.030761.309850.162832Myo1b−0.595032−1.098860.8906570.803232Cxcl12−0.377019−0.8397481.44875−0.23198Vcam1−0.118534−0.76449−0.5613941.44442Chchd21.12552−1.041780.525748−0.609493Arhgef12−0.728362−0.8014871.338030.191823Bcl20.699560.366960.417325−1.48384Cryab−0.831001−0.8255240.4705551.18597Tpm20.358849−0.06458771.0411−1.33536Stat3−0.951892−0.420543−0.0120861.38452Capza10.945866−0.945050.778122−0.778938Il1b1.47332−0.225586−0.622641−0.625097Rnd31.34749−0.5764980.141145−0.912138Slit2−0.72262−0.638973−0.0750361.43663Dnm2−0.296382−1.160681.230260.226806Emp2−0.964067−0.6786160.4601951.18249Marcksl11.2413−0.2746690.193641−1.16027Myc0.1848161.20839−0.179336−1.21387Mif1.49932−0.52861−0.458383−0.512332Fnbp10.540304−1.460990.7339850.186696Clec2d−0.773785−0.8630320.4203831.21643Crh1.2280.402804−0.815403−0.815403Smarca40.897716−0.9661860.827408−0.758938Rhoj−0.69625−0.6523731.44251−0.0938856Palld−0.0577830.008008091.24868−1.19891Pafah1b1−0.002853−1.058041.34217−0.281278Pik3r1−0.845334−0.292798−0.3118451.44998Fblim1−0.364685−1.247920.7376080.875Cdk60.385309−0.9581411.22701−0.654178Ctgf−0.476914−1.056910.2774271.2564S1pr1−0.673846−0.7006031.43239−0.0579363Shc11.07814−0.512540.558318−1.12392Coro1b0.085574−1.322881.107120.130185Mapk14−0.2419581.28682−1.130580.0857137Junb0.4109531.17702−1.09807−0.489902Mprip−0.666687−1.025811.034630.657863Rock10.158822−1.392640.9871590.246661Hax10.684126−1.477160.2632230.529807Akap130.0260559−1.18589−0.0984621.25829Gng12−0.35838−1.005891.363730.000544535Cdkn1a0.09162680.462374−1.42250.868503Gna13−0.44997−0.9361241.386072.05e−05Gnaq−0.091048−1.031931.36656−0.243584Sept90.555875−0.6844081.11649−0.987952Gna12−0.300922−0.8717651.44129−0.268605Sh3pxd2a−0.403176−0.8083651.45726−0.245722Prnp−1.327940.522858−0.1627630.967841Dab21.12043−1.10753−0.5153320.502433Mapre10.403968−0.8455791.22686−0.78525Fat10.7273810.5074630.234335−1.46918Clec7a1.49561−0.390523−0.549357−0.555734Table 4Computational transcriptional factor binding site motif enrichment analyzed in the differential gene expression pattern of six profiles.Table 5**ProfileGene/TF−log *P*val**Profile_1KLF329.92Profile_1ELK329.31Profile_1YBX119.67Profile_1SP119.52Profile_1HBP112.97Profile_1FOXF26.998Profile_1ID36.854Profile_1CUX13.526Profile_1**CTCF**2.103Profile_13KLF628.86Profile_13ELK413.64Profile_13SMARCC26.029Profile_13NFE2L14.113Profile_13NFIA3.98Profile_13NFIX3.98Profile_13MEF2A3.491Profile_13**MAX**2.221Profile_13FOXN33.203Profile_10RUNX34.56Profile_10JUNB4.264Profile_18KLF75.862Profile_23FOSB4.769Profile_39KLF436.43Table 5Previously published ChIP-Seq data with significant overlap of genes differentially expressed in CD140+ fibroblasts throughout lung development.Table 6**ProfileTrackCellTFOverlapTotalRatioEnrichment*p*-Val**Profile_1Caltech_TfbsC2C12NRSF2074650.453.415.80E−66Profile_1Licr_ChipMELCTCF2864650.622.224.26E−46Profile_13Sydh_TfbsCH12Max1932570.752.171.62E−37Table 6Genes identified in the ChIP-Seq enrichment analysis and differentially expressed in CD140+ cells.Table 7**CTCF & NRSFNRSFCTCFMAX**ACTN1ANAPC51110004F10RIK1700016K19RIKACTR2AP2M11700020I14RIKACAA2ANXA6ATP5B2700081O15RIKACO2AP3B1ATP6V0C-PS26820431F20RIKACTN4API5BRD2ACAT1ADD1ARPC1BCALD1ADNPADIPOR1ARPC2CALUANKRD11AHCYL1ARPC5CBX3ANKRD17AKAP12ATP5C1CDK11BANP32AANO6B230219D22RIKCFDP1ATF7IPAP2B1BCLAF1CNN3ATP5JARF4CALM2CXCL12ATXN2LARHGAP1CALM3DDX1BAZ1BARHGDIACANXDDX3XBC005537ARL8BCAPRIN1DHX15BPTFASAH1CAPZA1DLDBZW1ATL3CAPZA2EIF5CCND2ATP1A1CAPZBFKBP10CCNIATP1B3CCNYFOXF2CDC123ATP2A2CDC42FSTL1CDK6ATP6AP1CFL1FZD1CDV3ATP6V0D1CHD4GSK3BCLINT1ATP6V0ECKAP4GTF2A2CNN2ATP6V1ACOMMD3GTF3C6CNOT1BAG1COPS5HDAC2COPZ2BAG6CORO1CHNRNPH1CPDBCAP31CSNK1A1IDH3BCRTAPBRD7CUL3IMMTCTCFCALM1CYC1ITSN2CTDNEP1CAPNS1DDX39BKTN1CTDSP1CASTDENND5ALGALS1CUL1CCDC47DHX9MDH2CUX1CCNDBP1EID1NARSCXXC1CCNT1EIF3CNCOR1DDB1CD164EIF3DNDUFA10DNAJC10CD47EIF4G2NRD1DNAJC7CHMP2AEIF5BNSMCE2DNMT3ACHTOPEPB4.1L2NXF1DNTTIP2CIR1ERHPCNPEIF2S3XCLIP1EWSR1POMPEIF3GCLN5FBXO11PPP4R2EIF4A3COPAFKBP1APRCPEIF4G3COPEFLNAPRDX2ELK3COPG1FUSPSMB5ERBB2IPCR1LGDI2RCN2ESF1CRIPTGHRRHOAEXT2CSNK1G2GLUD1RNF4FAM120ACTDSP2GNB1RTN4FAM193ACTNNB1H3F3ASDCBPGALNT1CTSAHMGB3SETD5GINS4CTSBHMOX2SLC25A3GNG12CTSDHNRNPA0SND1GNG5CUTAHNRNPA2B1SNRNP200GOLGA7DAPHNRNPDLSNRNP70GPBP1DAZAP2HPRTSTRAPGSK3ADCTN4HTATSF1TAF13GTPBP4DCTN6ID3TRP53H1F0DDOSTIKTUBB6HDGFDEGS1ILF3VDAC3HIC1DHRS1IVNS1ABPVIMHIPK2DNAJA1KANSL1YBX1HMGN1DNAJB11KHDRBS1YEATS4HNRNPA3DPP8KLF3ZFP207HNRNPH2EGLN1KPNB1HNRNPLLEIF4EBP2LEO1HNRNPUL1EIF4ENIF1LRRC59ILKELK4LSM14AKLHDC2ELOVL5MBD2KLHL9EMC3MFSD1LARP4BEMC4MSL1LASP1EMC7MYH9LIX1LEP300NCBP2LSM12ERGIC3NDUFA12MAP4ERP29NEDD4MAP7D1ESYT1NUP62MAPK1IP1LETFAP4HBMAPKAP1FADS1PABPC1MAPRE1FAM114A1PAICSMAPRE2FBXO22PCBP1MIDNGANABPCBP2MRFAP1GM13363PFN1MTDHGM6644PNRC2MTSS1LGOLGA4POLR2ANDUFS2GORASP2PPP1CCNONOGRNPPP1R12ANRBP1GTF2BPPP3R1NUCKS1H2-K1PRELID1PABPN1HADHAPRKAR1APAPOLAHADHBPRPF40APCM1HAX1PRPF4BPDCD5HDLBPPRRC2APDS5AHECTD1PSMD11PICALMHIAT1PSMD12PITPNAHIPK1PSMD6POLR2MHNRNPUL2PTBP1PPP1CAHSP90B1PTP4A2PSMA7IFITM2PTPN12PSMC2IFT20QKPSMD1IQGAP1RAB10PTBP3IRF2BP2RAB14PTCH1ITFG1RAB6APTOV1JAGN1RAC1PUM2KCMF1RNF187RAD21KDELR2RNF7RAP1AKIF1BSCAF11RBBP6KLF6SENP6REREKMT2ESH3BGRL3RESTKRCC1SH3GLB1RRP1LAMP1SLTMSETD8LAMTOR5SMC6SHFM1LGALS9SRP72SHOC2LIMA1SRRM1SKAP2LIMS1SRSF2SKIV2L2LMAN1SRSF3SLKMAPK3SRSF5SMARCA4MAT2ASSR3SMARCE1MAXSTAG1SMOMEF2ASTMN1SNAI2MLF2STX12SNHG5MYL12ASUPT16SNX4NBR1TAB2SP1NCOA4TBL1XSPIN1NCSTNTCF12SUCLG2NDFIP1TFGSYNCRIPNFE2L1THRAP3TCEA1NFIXTMED9THOC7NISCHTMEM123TOMM22OCIAD1TMEM131TPRPAFAH1B2TMEM234TSPAN3PDHBTMPOUBE2E3PDIA4TOP2BUBE2IPDZD11TRIP12UBE2V1PHLDA1TTC3UBE4BPLXNB2TUBA1AUSP47PPP2R1ATUBB5UTP3PPT1VAMP3VCPPSMC5VDAC2WAPALPTPRSWDR1WDR26RAB1XRN2YWHABRAB7YTHDC1ZC3H15RAB9YWHAEZFP664RANBP9YWHAHZMYND11RAP2AYWHAQRCN1ZCRB1REEP5RHOBRNH1RTN3S100A11SAR1ASAR1BSEC. 31ASEC. 61A1SEC. 63SERINC1SIRT2SMDT1SNAPINSRPRSTAU1STT3ASTT3BSTX4ASTX5ASUPT6SWI5TAGLN2TAOK1TCF25TECRTLN1TM9SF2TMBIM6TMED10TMED2TMOD3TOR1AIP2TRAPPC6BTRP53BP2TUBB4BTXNDC5UBR5UBXN4UGP2USP16USP8VGLL4VPS25VPS28YWHAGZFP106ZMIZ1ZYX

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Animals {#s0015}
------------

B6.129S4-*PDGFRα*^*tm11**(EGFP)**Sor*^/J mouse-line herein designated PDGFRα^GFP^ [@bib2], with PDGFRα promoter driving the expression of the H2B-eGFP fusion gene were used for immunohistochemical, differential plate-down, and flow cytometry analyses. Mice lacking the PDGFRα GFP tag were used for PDGFRα^+^ cell RNA-Seq analysis.

2.2. Confocal microscopy {#s0020}
------------------------

Lung tissues were harvested, fixed with 4% PFA in PBS and frozen. Tissue was sectioned into 200 μm slices and stained with anti-αSMA (Sigma-Aldrich, St. Louis, MO), Pro-SPC and chicken polyclonal anti-GFP antibody (Abcam, Cambridge, MA). Data was analyzed by Imaris software, version 7.6.

2.3. Characterization of PDGFRα^GFP^ Cells by flow cytometry in plate-adhered or suspension cells {#s0025}
-------------------------------------------------------------------------------------------------

Lung tissue from PDGFRα^GFP^ mice was harvested, processed into single cell suspension as previously described [@bib3]. Cells were incubated in Dulbecco׳s DMEM/F12 (10% FBS, 2% pen/strep) after 2 h of culture, the media containing the non-adherent cell fraction was collected, and the adherent fraction was collected using Accutase (1× ACCUTASE enzymes in Dulbecco׳s PBS (0.2 g/L KCl, 0.2 g/L KH~2~PO~4~, 8 g/L NaCl, and 1.15 g/L Na~2~HPO~4~) containing 0.5 mM EDTA·4Na and 3 mg/L Phenol Red).

2.4. Bioinformatics data analysis {#s0030}
---------------------------------

RNA-Seq data was quantitated using TopHat and Cufflinks [@bib4], genes were included with the expression level (FPKM) was more than 1 in all samples. Bayesian Analysis of Time Series (BATS) identified genes as differentially expressed at one or more timepoints, co-regulated genes were identified by using pattern recognition using STEM and grouped into Gene expression profiles. Gene expression profiles were subjected to gene set enrichment analysis with Toppgene and Toppcluster [@bib5], [@bib6], [@bib7].

2.5. Transcription factor promoter enrichment analysis {#s0035}
------------------------------------------------------

Transcription factor promoter enrichment analysis of PDGFRα^+^ fibroblast RNA-Seq profiles identified three candidate transcription factors: NRSF/REST, CTCF, and MAX. ChIP-Seq has been performed in the following mouse cell lines, and the data available in the public domain:MAX: <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM912908>CTCF: <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM918744>NRSF/REST: <https://www.encodeproject.org/experiments/ENCSR000AIS/>

To identify potential candidate genes in PDGFRα^+^ fibroblasts regulated by NRSF/REST, CTCF, or MAX during acinar lung development, we cross-referenced the dynamically regulated genes identified by our present RNA-Seq analysis with the above, previously-published gene sets [@bib1].
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